← Leaderboards
Raymond Joseph Budde
Houston Pharmaceuticals, Inc.
$298,934
Attributed
$298,934
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$298,934 · 1
By mechanism
N43$298,934 · 1
Top collaborators
No co-investigators on record.
Most similar at Houston Pharmaceuticals, Inc.
Same institution · by research overlap
- Raymond J Budde$1,574,986
Others in their field
Top investigators on “Affinity”
- Dennis R. Burton · Scripps Research Institute$64,397,776
- James E Crowe · Vanderbilt University Medical Center$53,471,415
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$45,445,140
- Timothy A Springer · Boston Children'S Hospital$41,593,445
- Misty Ward Stevens · Intervexion Therapeutics, Llc$38,187,594
- Rafi Ahmed · Emory University$36,776,987
Research focus
AffinityBindingBiodistributionCellsClinically RelevantDesignDetectionDiagnosisDoseDrug KineticsIn VitroIn VivoLigandsMalignant Neoplasm Of PancreasMalignant NeoplasmsMolecular TargetNeoplasm MetastasisNormal Tissue MorphologyOutcome ForecastPositronPositron-Emission TomographyPrimary NeoplasmPropertyRadiation